Illumina Wins Case Against FTC on Grail Acquisition

by | Sep 1, 2022 | Business

By Peter Loftus and Dave MichaelsUpdated Sept. 1, 2022 5:44 pm ETListen to article(2 minutes)An administrative law judge has ruled in favor of Illumina in its $7.1 billion acquisition of cancer-testing developer Grail Inc., dealing a defeat to the Federal Trade Commission’s efforts to unwind the deal on antitrust grounds, the company said.Illumina said the judge rejected the FTC’s position that the deal would hurt competition in the market for multicancer early-detection tests.

Article Attribution | Read More at Article Source

Share This